United States - English - NLM (National Library of Medicine)

a-s medication solutions - lithium carbonate (unii: 2bmd2gna4v) (lithium cation - unii:8h8z5uer66) - lithium carbonate is indicated in the treatment of manic episodes of maniac-depressive illness. maintenance therapy revents or diminishes the intensity of subsequent episodes in those maniac-depressive patients with a history of mania.  typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, elation, poor judgment, aggressiveness, and possibly hostility. when given to a patient experiencing a manic episode, lithium carbonate may produce a normalization of symptomatology within 1 to 3 weeks.

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

fujinaga pharmaceutical co.,ltd. - lithium carbonate - white tablet, diameter: 7.0 mm, thickness: 3.2 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

daiichi sankyo company, limited - lithium carbonate - white tablet, diameter: 7.0 mm, thickness: 3.2 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

fujinaga pharmaceutical co.,ltd. - lithium carbonate - white tablet, diameter: 8.5 mm, thickness: 4.6 mm

Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

daiichi sankyo company, limited - lithium carbonate - white tablet, diameter: 8.5 mm, thickness: 4.6 mm